Ottobock invests in NeuroTech company ONWARD® Medical
mehr
Storys zum Thema Therapie
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
RHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
mehr- 2
Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.
Ein Dokumentmehr - 10
Gerresheimer: New pictures available
mehr Gerresheimer expands capacities for Medical Systems in the USA
mehrDr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment
mehrResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
mehrRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target
mehrBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy
mehrNew Source of Stem Cells in Injury-Affected Brains of Patients
mehr- 2
Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey reveals
Ein Dokumentmehr A New Ally in Fighting Brain Diseases: Our Very Own Skull
mehr- 2
CARAMBA: New Hope for Multiple Myeloma Patients
mehr New Approach in Cancer Therapy With Innovative Mechanism-of-Action for Ferroptosis Induction
mehrRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
mehrThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remission
mehrStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa research
mehrKlinik für Prostata-Therapie Heidelberg
Focal therapy for prostate cancer: Reliable diagnosis leads to gentle treatment
mehrPress Information: Ottobock strengthens its NeuroMobility business area
mehrNew Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inostics
mehrGastrulation research reveals novel details about embryonic development
mehrInvestment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns / Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG shares worth EUR 15M
mehr- 3
High-tech prosthesis for enhanced safety: New Kenevo knee joint available
mehr - 2
Lindis Biotech develops immunotherapy against bladder cancer
Ein Dokumentmehr - 3
World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic tools
Ein Dokumentmehr Merger: Newly-formed Semdor Pharma Group becomes one of Europe's leading pharmaceutical companies for narcotics and medical cannabis
mehrRegulatory breakthrough for BrainRepair UG start-up - Stem cell treatment for newborns /EMA Orphan Drug Designation is followed by agreement on Paediatric Investigation Plan
mehr- 2
Innovation: Intelligent bacteria demonstrate high efficacy in the treatment of widespread disease irritable bowel syndrome with typical symptoms of recurrent diarrhoea, abdominal pain, bloating and constipation
mehr - 2
Beta cells from stem cells: Potential for cell replacement therapy
mehr Hitachi Medical Systems Europe Holding AG
2Hitachi and Centre Léon Bérard cancer center in Lyon to launch a research collaboration in the fight against cancer with AI
mehr
12Nächste